miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients (2010)
- Authors:
- USP affiliated authors: SILVA JUNIOR, WILSON ARAÚJO DA - FMRP ; SIMOES, BELINDA PINTO - FMRP ; COVAS, DIMAS TADEU - FMRP ; SOUZA, ANA MARIA DE - FCFRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP
- Unidades: FMRP; FCFRP
- Subjects: LEUCEMIA MIELOIDE AGUDA; EXPRESSÃO GÊNICA; APOPTOSE
- Language: Inglês
- Imprenta:
- ISBN: 9788589109062
- Source:
- Título do periódico: Anais Eletrônicos
- Conference titles: Congresso Brasileiro de Genética
-
ABNT
FERREIRA, A. F. et al. miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients. 2010, Anais.. Guarujá: SBG, 2010. Disponível em: http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp. Acesso em: 19 set. 2024. -
APA
Ferreira, A. F., Simoes, B. P., Silva Júnior, W. A. da, Silva, I. T., Zanichelli, M. A., Colassanti, M. D., et al. (2010). miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients. In Anais Eletrônicos. Guarujá: SBG. Recuperado de http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp -
NLM
Ferreira AF, Simoes BP, Silva Júnior WA da, Silva IT, Zanichelli MA, Colassanti MD, Hamerschlak N, Covas DT, Kashima S, Souza AM de, Castro FA de. miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients [Internet]. Anais Eletrônicos. 2010 ;[citado 2024 set. 19 ] Available from: http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp -
Vancouver
Ferreira AF, Simoes BP, Silva Júnior WA da, Silva IT, Zanichelli MA, Colassanti MD, Hamerschlak N, Covas DT, Kashima S, Souza AM de, Castro FA de. miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients [Internet]. Anais Eletrônicos. 2010 ;[citado 2024 set. 19 ] Available from: http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp - Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis
- Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia
- PRV-1 overexpression in essential thrombocythemia correlates with trail expression
- Apoptomirs expression profile in polycythemia vera patients
- Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]
- Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
- Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy
- Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia
- The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
